Customs and Border Protection
-
Comments to CBP Regarding Its Proposal to Amend US Customs and Border Protection Regulations Pertaining to Disclosure of Information Regarding Abandoned Merchandise
November 15, 2019
The American Intellectual Property Law Association submitted a letter to US Customs and Border Protection (CBP) to present its views with respect to the Notice of Proposed Rulemaking to Amend U.S. Customs and Border Protection Regulations Pertaining to Disclosure of Information Regarding Abandoned Merchandise 19 CFR Parts 127 and 133 dated August 27 2019 (the NPRM). -
Letter in Support of CBP's Efforts to Modernize
February 2, 2019
The American Intellectual Property Law Association submitted a letter to the US Customs and Border Protection (CBP) supporting its efforts to modernize to meet the challenges of today’s trade environment and to proactively prepare for future trade environments, particularly as the importance of intellectual property rights in the global economy continues to rise. -
Comments to CBP Regarding Its Proposal to Amend 19 CFR Parts 133 and 151
July 25, 2012
The American Intellectual Property Law Association submitted a letter to US Customs and Border Protection (CBP) to aid the Agency with its proposal to amend 19 CFR Parts 133 and 151 to clarify and expand the information disclosed to intellectual property rights holders in an effort to combat counterfeiting.
Recent Advocacy
-
AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace
May 14, 2024
Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace. -
AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.
May 14, 2024
Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state. -
Supreme Court Affirms Eleventh Circuit’s Ruling in Warner Chappell Music, Inc. v. Sherman Nealy
May 9, 2024
On May 9, 2024, the Supreme Court issued a 6-3 decision in Warner Chappell Music, Inc., et al. v. Sherman Nealy, et al., affirming the Eleventh Circuit’s ruling that, provided suit is timely filed under the discovery rule, copyright damages are recoverable for infringements occurring prior to the Copyright Act’s three-year statute of limitations. The majority opinion is consistent with the amicus brief filed by AIPLA on December 1, 2023. To read the opinion of the Court, please click here.
-
AIPLA Files Brief in Support of None of the Parties in Abitron Austria GmbH v. Hetronic International, Inc.
January 1, 2023
Arlington, VA. January 1, 2023 - The American Intellectual Property Law Association (AIPLA) filed a merits-stage amicus curiae brief in the U.S. Supreme Court case of Abitron Austria GmbH et al. v. Hetronic Int’l Inc., Case. No. 21-1043. -
AIPLA Comments on the Draft Amendment of the Anti-Unfair Competition Law of the People's Republic of China
December 22, 2022
Arlington, VA. December 22, 2022 - The American Intellectual Property Law Association (AIPLA) submitted comments to China’s State Administration of Market Regulation on the Draft Amendment of the Anti-Unfair Competition Law of the People's Republic of China.
-
AIPLA Comments on the Draft Revised Chinese Patent Examination Guidelines
December 19, 2022
Arlington, VA. December 19, 2022 - The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) on the Draft Revised Chinese Patent Examination Guidelines.
-
AIPLA Comments on USPTO’s Diversion Program
November 10, 2022
Arlington, VA. November 7, 2022 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office on the Office of Enrollment and Discipline’s (OED) Diversion Pilot Program. -
AIPLA Comments to USPTO on Subject Matter Guidance
October 21, 2022
Arlington, VA. October 21, 2022 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office on the Office’s guidance on patent subject matter eligibility under Section 101 of the Patent Act.